A carregar...
Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer
There are few approved drugs available for the treatment of patients with non-muscle invasive bladder cancer (NMIBC) and none have been approved in the twenty-first century. Four drugs; thiotepa in 1959, BCG Tice in 1989, BCG Connaught in 1990, and valrubicin in 1998, have been approved for the trea...
Na minha lista:
| Publicado no: | Bl Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
IOS Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4832566/ https://ncbi.nlm.nih.gov/pubmed/27088122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-150016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|